Free $25 Amazon Gift Card*
Background. At least eleven (11) genetically distinct gene products are collectively referred to as 'collagen types' or other proteins and proteoglycans of the extracellular matrix. In humans, collagens are composed of about twenty (20) unique protein chains that undergo various types of post-translational modifications and are ultimately assembled into a triple helix. This results in great diversity between collagen types. Collagens are highly conserved throughout evolution and are characterized by an uninterrupted "Glycine-X-Y" triplet repeat that is a necessary part of the triple helical structure.
For these reasons, generating type specific antibodies to collagens presents unique challenges. It is an absolute requirement to use non-denatured three-dimensional epitopes to develop these type specific antibodies. Rockland extensively purifies collagens for immunization from human and bovine sources by limited pepsin digestion and selective salt precipitation. This maintains the three-dimensional structure of the collagen.
After isolation from rabbit antiserum, these antibodies are repeatedly and exhaustively cross-adsorbed by immunoaffinity purification to produce 'type' specific antibodies that are well suited to detect extracellular matrix proteins in normal and disease state tissues. For instance, anti-Collagen Type I is first purified against immobilized type I collagen and then is passed over immobilized type II collagen repeatedly until no additional antibody is bound. This process is applied successively for all other collagen types rendering the Collagen Type I antibody specific for collagen I with minimal cross reactivity to all other collagen types.
Critical Thinking. Because Rockland collagen antibodies are designed with specificity to recognize only non-denatured three-dimensional epitopes, assays that maintain native collagen structure work best. For ELISA, capture (a.k.a. sandwich) ELISA is recommended. A “titering” ELISA, on the other hand, is not recommended because the native collagen structure is disrupted when collagen is directly bound to the ELISA plate. As a result, loss of detection specificity may occur due to: (1) incomplete binding to the plate for some collagen types, (2) partial denaturation of some collagens, and/or (3) partial or incomplete blocking.
This protocol accounts for the design and function of these collagen antibodies to optimize the specificity of the antibody. Deviations to the protocol are encouraged but may require additional optimization by the end user to preserve antibody specificity.
Reagents Required. The following blocking reagents, capture antibodies, collagen analytes, detection antibodies, and detection reagents are recommended for this assay:
Figure. Capture ELISA using Rockland collagen antibodies designed to recognize non-denatured three-dimensional epitopes present within native collagen structure. Anti-Collagen Type I was used to capture Human Collagen Type I and other human collagens. Detection occurred using anti-Collagen Type I Biotin Conjugate followed by reaction with streptavidin HRP and TMB substrate.
Rockland Immunochemicals Inc.Limerick, PA 19468E-mail: email@example.comPhone: 800.656.7625